BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Depomed, Inc. Reports Top Line Data for Phase 2 Study in Parkinson’s Disease

  November 8, 2012

   · 

  4 min read
• Business

  Meridian Bioscience, Inc. Reports Fourth Quarter and Full-Year 2012 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance

  November 8, 2012

   · 

  1 min read
• Atrium Innovations Announces the Renewal of Its Normal Course Issuer Bid

  November 8, 2012

   · 

  4 min read
• Genetown

  Ariad Pharmaceuticals, Inc. to Present at the Lazard Capital Markets Healthcare Conference

  November 8, 2012

   · 

  1 min read
• Pharm Country

  Durata Therapeutics, Inc. to Present at Credit Suisse 2012 Healthcare Conference

  November 8, 2012

   · 

  1 min read
• Business

  InViragen and the International Vaccine Institute Expand Partnership

  November 8, 2012

   · 

  1 min read
• Policy

  BioSpecifics Technologies Corporation Announces Submission of Supplemental Biologics License Application to FDA for XIAFLEX® for Treatment of Peyronie’s Disease

  November 8, 2012

   · 

  6 min read
• BioMidwest

  Alkermes plc’ Corporate Presentation to be Webcast at Two Upcoming Conferences

  November 8, 2012

   · 

  1 min read
• Drug Development

  ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase 3 With Fibrocaps™ and Successfully Concludes Safety Review Assessment

  November 8, 2012

   · 

  1 min read
• BioMidwest

  Mesa Labs Increases Quarterly Dividend

  November 8, 2012

   · 

  2 min read